Evaluation of Serum Humanin and MOTS-c Peptide Levels in Patients with COVID-19 and Healthy Subjects
Journal:
Current Protein & Peptide Science
Volume:
24
Page:
277-283
Author(s):
Ahmet Saracaloglu*, Ayşe Özlem Mete, Duran Furkan Ucar, Seniz Demiryürek, Enes Erbagcı and Abdullah Tuncay Demiryürek
Effects of Lunar Phases on Foot Temperature, Oxidative Stress, and Inflammation in Type 2 Diabetic Subjects
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
23
Page:
832-842
Author(s):
Koena Bhattacharjee, Subhasish Pramanik, Sutanu Dutta Chowdhury*, Barnali Ray Basu and Lakshmi Kanta Mondal*
An Overview of Thrombin Inhibitors in the Perspective of Structureactivity Relationships
Journal:
Current Medicinal Chemistry
Volume:
30
Page:
2864-2930
Author(s):
Jiangming Wang, Xiaojing Sun, Na Li, Ruilong Sheng and Ruihua Guo*
Involvement of Metabolites and Non-coding RNAs in Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
24
Page:
889-912
Author(s):
Kubra A. Coskun, Bercem Yeman Kıyak, Kezban Ucar Cifci, Elif Kadioglu, Nazlican Yurekli and Yusuf Tutar*
Role of Flavonoids in Management of Various Biological Targets in Alzheimer’s Disease: Evidence from Preclinical to Clinical Studies
Journal:
Current Medicinal Chemistry
Volume:
30
Page:
2061-2074
Author(s):
Khalid Saad Alharbi, Mohammad Arshad Javed Shaikh, Syed Sarim Imam, Sultan Alshehri, Mohammed M. Ghoneim, Waleed Hassan Almalki, Sachin Kumar Singh, Deepak Kumar, Avvaru Praveen Kumar, Kamal Dua, Dinesh Kumar Chellappan, Keshav Raj Paudel and Gaurav Gupta*
Exploration of Pharmacological Potential of Alpinetin
Journal:
Current Nutrition & Food Science
Volume:
19
Page:
238-245
Author(s):
Dhirendra Singh and Randhir Singh*
Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?
Journal:
Current Medicinal Chemistry
Volume:
30
Page:
1798-1812
Author(s):
Prema Robinson*, Rafael Coveñas and Miguel Muñoz*
Berberine: Is it a Promising Agent for Mental Disorders Treatment?
Journal:
Current Molecular Pharmacology
Volume:
16
Page:
307-320
Author(s):
Mehran Shayganfard*
Anaphylaxis in Risky Populations
Journal:
Current Pharmaceutical Design
Volume:
29
Page:
224-238
Author(s):
Şengül Beyaz and Aslı Gelincik*
Imaging Markers of Neurologic Damage in COVID-19: A Systematic Review
Journal:
Current Medicinal Chemistry
Volume:
30
Page:
1086-1106
Author(s):
Sara Tavares Araújo, Clara Tavares Araújo, Rafael Silva e Castro, Lara Machado de Oliveira Brügger, Nathália Gualberto Souza e Silva, Debora Marques de Miranda and Ana Cristina Simões e Silva*